Hepatology Reviews

Virtual Issues
12 April 2020
12 February 2021
Export Citation(s)Download PDF(s)

Volume 67, Issue 4

Free Access

The rise of the opioid epidemic and hepatitis C–positive organs: A new era in liver transplantation

Stevan A. Gonzalez,  James F. Trotter, 
Free Access

Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia

Ryoichi Fujiwara,  Mathias Haag,  Elke Schaeffeler,  Anne T. Nies,  Ulrich M. Zanger,  Matthias Schwab, 

Volume 67, Issue 3

Open Access

Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma

Mohamed Bouattour,  Eric Raymond,  Shukui Qin,  Ann-Lii Cheng,  Uz Stammberger,  Giuseppe Locatelli,  Sandrine Faivre, 
Free Access

Reassessing the safety concerns of utilizing blood donations from patients with hemochromatosis

Adam C. Winters,  Douglas Tremblay,  Suzanne Arinsburg,  John Mascarenhas,  Thomas D. Schiano, 

Volume 67, Issue 2

Free Access

Engaging hepatitis C infected patients in cost-effectiveness analyses: A literature review

T. Joseph Mattingly II,  Eleanor M. Perfetto,  Sophia L. Johnson, 
Free Access

Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology

Anna Pellat,  Javier Vaquero,  Laura Fouassier, 

Volume 67, Issue 1

Free Access

Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis

Lewis R. Roberts,  Claude B. Sirlin,  Feras Zaiem,  Jehad Almasri,  Larry J. Prokop,  Julie K. Heimbach,  M. Hassan Murad,  Khaled Mohammed, 
Free Access

Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis

Richard S. Finn,  Andrew X. Zhu,  Wigdan Farah,  Jehad Almasri,  Feras Zaiem,  Larry J. Prokop,  Mohammad Hassan Murad,  Khaled Mohammed, 
Free Access

Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis

Laura Kulik,  Julie K. Heimbach,  Feras Zaiem,  Jehad Almasri,  Larry J Prokop,  Zhen Wang,  M. Hassan Murad,  Khaled Mohammed, 

Volume 66, Issue 6

Free Access

Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B

Xupeng Hong,  Elena S. Kim,  Haitao Guo, 
Free Access

Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis

Rahima A. Bhanji,  Praveena Narayanan,  Alina M. Allen,  Harmeet Malhi,  Kymberly D. Watt, 

Volume 66, Issue 5

Free Access

Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group

Christoph Schramm,  John Eaton,  Kristina I. Ringe,  Sudhakar Venkatesh,  Jin Yamamura,  for the MRI working group of the IPSCSG , 

Volume 66, Issue 4

Free Access

Large-scale computational models of liver metabolism: How far from the clinics?

Tanja Cvitanović,  Matthias C. Reichert,  Miha Moškon,  Miha Mraz,  Frank Lammert,  Damjana Rozman, 
Free Access

Acute hepatic porphyrias: Recommendations for evaluation and long-term management

Manisha Balwani,  Bruce Wang,  Karl E. Anderson,  Joseph R. Bloomer,  D. Montgomery Bissell,  Herbert L. Bonkovsky,  John D. Phillips,  Robert J. Desnick,  for the Porphyrias Consortium of the Rare Diseases Clinical Research Network , 

Volume 66, Issue 3

Free Access

Prevention and treatment of complications of selective internal radiation therapy: Expert guidance and systematic review

Bruno Sangro,  Diego Martínez-Urbistondo,  Lourens Bester,  Jose I. Bilbao,  Douglas M. Coldwell,  Patrick Flamen,  Andrew Kennedy,  Jens Ricke,  Ricky A. Sharma, 

Volume 66, Issue 2

Free Access

Drug rechallenge following drug-induced liver injury

Christine M. Hunt,  Julie I. Papay,  Vid Stanulovic,  Arie Regev MD, 

Volume 66, Issue 1

Free Access

Augmenter of liver regeneration: A fundamental life protein

Michael A. Nalesnik,  Chandrashekhar R. Gandhi,  Thomas E. Starzl, 
Free Access

Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation

Lucy Golden-Mason,  Hugo R. Rosen, 

Volume 65, Issue 6

Free Access

Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review

Veeral H. Ajmera,  Norah A. Terrault,  Stephen A. Harrison, 
Free Access

Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic

Iliana Doycheva,  Kymberly D. Watt,  Naim Alkhouri,